The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis

Neoadjuvant chemotherapy is being increasingly accepted as an effective treatment of resectable colorectal liver metastases (CRLM), but it may also damage the hepatic parenchyma. We performed a meta-analysis to compare the outcomes of patients who received neoadjuvant chemotherapy (NEO) prior to hep...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei, Zhou, Jian-Guo, Sun, Yi, Zhang, Lei, Xing, Bao-Cai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095075/
https://www.ncbi.nlm.nih.gov/pubmed/27074564
http://dx.doi.org/10.18632/oncotarget.8671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095075/
https://www.ncbi.nlm.nih.gov/pubmed/27074564
http://dx.doi.org/10.18632/oncotarget.8671

Ejemplares similares